Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Twelves

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Onkologie|September 13, 2007
Docetaxel weekly with metastatic breast cancerChris Twelves
Nature Clinical Practice. Oncology|November 22, 2007
Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?Chris Twelves
Expert Review of Anticancer Therapy|March 13, 2013
Trials and tribulations of cytotoxic and targeted breast cancer therapy: a clinical perspective on the next phase of progress. Interview by Sophia Maprayil and Alexandra HemsleyChris Twelves
Clinical Colorectal Cancer|November 28, 2002
Capecitabine (Xeloda): from the laboratory to the patient's homeGeorge Pentheroudakis, Chris Twelves
The Breast Journal|November 30, 2019
Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: A post hoc pooled analysisJavier Cortes, Chris Twelves
Future Medicinal Chemistry|March 8, 2013
Tubulin: an example of targeted chemotherapyJenny Seligmann, Chris Twelves
British Journal of Cancer|April 14, 2021
Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive frameworkKamal S Saini, Chris Twelves
BMJ (Clinical Research Ed.)|November 14, 2009
Legislation is needed to stop children using sunbedsCatherine S Thomson, Chris Twelves
Current Clinical Pharmacology|April 22, 2010
Scheduling of taxanes: a reviewEmma J Woodward, Chris Twelves
European Journal of Cancer (Oxford, England : 1990)|June 3, 2008
Loading doses for costly cancer biologicals: a cause for concern or tilting at windmills?Ivo M Hennig, Chris Twelves
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Onkologie|September 13, 2007
Docetaxel weekly with metastatic breast cancerChris Twelves
Nature Clinical Practice. Oncology|November 22, 2007
Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?Chris Twelves
Expert Review of Anticancer Therapy|March 13, 2013
Trials and tribulations of cytotoxic and targeted breast cancer therapy: a clinical perspective on the next phase of progress. Interview by Sophia Maprayil and Alexandra HemsleyChris Twelves
Clinical Colorectal Cancer|November 28, 2002
Capecitabine (Xeloda): from the laboratory to the patient's homeGeorge Pentheroudakis, Chris Twelves
The Breast Journal|November 30, 2019
Impact of the number of prior chemotherapy regimens on outcomes for patients with metastatic breast cancer treated with eribulin: A post hoc pooled analysisJavier Cortes, Chris Twelves
Future Medicinal Chemistry|March 8, 2013
Tubulin: an example of targeted chemotherapyJenny Seligmann, Chris Twelves
British Journal of Cancer|April 14, 2021
Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive frameworkKamal S Saini, Chris Twelves
BMJ (Clinical Research Ed.)|November 14, 2009
Legislation is needed to stop children using sunbedsCatherine S Thomson, Chris Twelves
Current Clinical Pharmacology|April 22, 2010
Scheduling of taxanes: a reviewEmma J Woodward, Chris Twelves
European Journal of Cancer (Oxford, England : 1990)|June 3, 2008
Loading doses for costly cancer biologicals: a cause for concern or tilting at windmills?Ivo M Hennig, Chris Twelves
Pageof 11